Current Evidence-Based Cessation Treatments: Efficacy and Critical Ingredients Saul Shiffman.

Slides:



Advertisements
Similar presentations
2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
Advertisements

STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Using New Communication Technologies to Enhance Services at Smoking Quitlines Lorien Abroms, ScD. Dept. of Prevention & Community Health GW School of Public.
Integrated Dual Diagnosis Treatment
Basma Y. Kentab MSc. Department of Clinical Pharmacy May 2014.
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
First RCT of Web-Based Acceptance & Commitment Therapy For Smoking Cessation: 3 Month Processes & Outcomes Jonathan B. Bricker, PhD Fred Hutchinson Cancer.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
What we need to know about smoking & tobacco addiction.
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
1 David B. Abrams, Ph.D National Conference on Tobacco or Health Dec Boston The Centers for Behavioral & Preventive Medicine Brown Medical School,
Seal of Approval Breakthrough Group Patty Mabry, Ph.D. Office of Behavioral and Social Science Reasearch NIH.
Analysis of MDS Data Deborah J. Ossip-Klein, Ph.D. University of Rochester Medical Center 2005 NAQC Annual Membership Meeting Chicago.
Laws/Policies ABSTRACT Problem: A challenge for tobacco control practitioners is getting smokers to quit using cessation methods. To increase the proportion.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
1 Current Evidence-Based Cessation Treatments: Efficacy and Critical Ingredients Saul Shiffman.
Why Quitlines Work Shu-Hong Zhu, Ph.D Gary Tedeschi, Ph.D. University of California, San Diego NAQC Annual Membership Meeting, Chicago May 2-3, 2005, Chicago.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
1 Recent studies of clinical significance University College London June 2011 Robert West.
Effectiveness of interventions to aid smoking cessation Robert West University College London September 2008.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Barbara Silver, MA, CTTS, Carol Ripley-Moffitt, MDiv, CTTS, Jillian E. Harris, BASW, Mark Gwynne, MD, Adam Goldstein, MD, MPH Nicotine Dependence Program.
Fax to Assist On-line Training for Certification Sponsored by Maryland Department of Health and Mental Hygiene and University of Maryland Baltimore County.
The Impact of Smoking Cessation Interventions by Multiple Health Professionals Lawrence An, MD 1 ; Steven Foldes, PhD 2 ; Nina Alesci, PhD 1 ; Patricia.
+ Interdisciplinary Care in Pediatric Chronic Pain Emily Law, PhD Assistant Professor Department of Anesthesiology & Pain Medicine University of Washington.
1 What does evidence-based behavioural support for smoking cessation look like? University College London UK Centre for Tobacco Control Studies National.
Chapter 21, lesson 2 objective:
Conclusions and Awards
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Smoking Cessation Medication
Dissemination and Implementation Research
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention, and referral to treatment
Overview of guidance/frameworks
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
FDA Authority to Regulate Tobacco Products Tobacco Control Act
Providing smoking cessation treatment: opportunities and challenges
Smoking and smoking cessation in the real world
Drugs and Neuron Communication
Development and Implementation of a Tobacco Cessation Toolkit
Why and How to Quit Smoking
Robert West University College London WCTOH Washington 2006
Module 8: Relapse Prevention
Robert West University College London London March 2008
Employer Perspective: Value of Integrated Models and Future Needs
Behavioural and pharmacological approaches to treating smokers
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Cessation Guidelines for COPD
Evidence from reviews of behavioural interventions
Nicotine replacement therapy
0% A BETTER WAY: PROMOTING AGENCY
Tobacco Cessation Coverage
Effective Treatment Planning
Describe and Evaluate the Cognitive Treatment for Schizophrenia
2009 Papers of Interest David Tinkelman.
Prepared by staff in Prevention and Cancer Control.
Smoking Cessation Smoke Signals.
David Levy, Ph.D. Dave Abrams, Ph.D. & Patty Mabry, Ph.D. May 3, 2006
Organizational Culture
Public/Population Health Approach to Substance Abuse Prevention & Treatment Determine the Burden of Substance Abuse and Service Barriers to Develop Plan.
Contemporary Issues of HRM
Tobacco Cessation for Primary Care Providers
Smoking Cessation.
Presentation transcript:

Current Evidence-Based Cessation Treatments: Efficacy and Critical Ingredients Saul Shiffman

Outcome of Smoking Cessation without Treatment 47% report trying to quit annually 13% of unaided quit efforts don’t last 24 h Sustained unaided quit rate <3%

Pharmacologic treatment Behavioral treatment Pharmacologic treatment

Behavioral Treatment Aimed at assisting behavior change Practical psycho-educational approach Based on cognitive-behavioral treatment principles “Multi-component” mix dominates Few/no “brand-name” differentiated treatment approaches Little/no content innovation in 20 years

Active Ingredients in Behavioral Programs Information Motivation enhancement Encouragement Support Planning & problem-solving Tips & techniques Medication support Process orientation Structure Conceptual Temporal A specific, step-by-step, pathway to quitting Contact, engagement, caring Lifestyle change

Effectiveness of Behavioral Treatment Components Guess which treatment is no longer in current use * Significantly better than nothing Source: AHRQ analysis: 2000

More is Better Source: AHRQ analysis: 2000

Developments in Behavioral Treatment Little/no content innovation Innovations in delivery modality & dissemination Channels Media Providers Packaging Duration

The Old & New Models of Behavioral Treatment Old way New way Approach Cognitive-behavioral Medium Face-2-face Phone, web Delivery model Central De-centralized Provider Semi-Pro Para-pro, computer Scripting Ad-lib Scripted Intensity High Low-Medium Medication Negative Integrate

Some Low-Intensity, Convenient Forms Are Ineffective Source: AHRQ analysis: 2000

Effectiveness Rises with Intensity Source: AHRQ analysis: 2000

Targeting to Groups By gender, ethnicity, age, disease, etc, etc No evidence they require different approaches Targeted materials may be more appealing Situations that affect the challenge & need may need different approach e.g., pregnancy, acute abstinence in hospital

Tailoring to Individuals One size does not fit all Assess user Tailor content, emphasis, sequence to individual characteristics and needs Model what a counselor would do Greater utilization, satisfaction Improved efficacy

Pharmacologic treatment Behavioral treatment Pharmacologic treatment

Pharmacological Treatment Meant to address dependence-related symptoms Nicotine Replacement Therapy (NRT) Patch Gum Lozenge Puffer Nasal spray Bupropion New compounds, approaches coming (Frank Vocci) OTC

All Medications Effective; About Equally Effective Studies vary in populations, behavioral intervention, and length of follow-up Source: AHRQ analysis: 2000

Combining Medications Enhances Efficacy No combination approved by FDA gum, puffer, nasal spray Source: AHRQ analysis: 2000

Innovation in Dissemination: OTC Marketing Increased Utilization Zyban intro Nasal Spray Patch mania OTC switch Estimated Assisted Quit Attempts (in thousands) Burton et al, MMWR, 2000

Pharmacologic treatment Behavioral treatment Pharmacologic treatment

Pharmacological & Behavioral Treatments: Additive Effects RR = 1.9 Pharm RR = 1.5 Beh RR = 1.7 Beh RR = 1.9 Silagy meta-analysis

Treatment Options: Approximate Effectiveness

Impact of Treatment Depends on Utilization Impact (# of quits) = Efficacy (% quit) X Utilization (# using method)

Treatment Options: Most Effective are Least Used Least effective methods most used 1% 8% 1% 11% 7% 72%

Even Among NRT Users Compliance is Poor – and it Matters Average nicotine gum use ~ 4/day

Status of Cessation Treatment and Goals for Change Efficacy Low High Reach Present

Barriers to Treatment Use Behavioral Tx Disconnect on mechanism Don’t see a need Injury to esteem Doubt efficacy Cost Mostly non-cash Pharmacological Tx Disconnect on mechanism Don’t see a need Injury to esteem Doubt efficacy Doubt safety Cost Mixed empirical support

We Are Reaching Only The Tip of the Iceberg Actually trying to quit 5% Not currently interested in quitting 56% Interested in quitting, not ready to quit now 26% Preparing to try quitting 13% Our Church of Perpetual Abstinence Sources: NHIS 2000, DiClemente et al, 1991

Building Demand “Build it, they will come” Marketing: product, positioning, packaging, promotion Figure out what people want Explain what it is Explain why they need it Make it pleasant, palatable, effective Make it cool Different strokes for different folks Make it, attractive, accessible, & convenient Promote it (repeatedly) Maintain a continuing relationship & system of care – not!

NOT!